ProQR Therapeutics (PRQR) Stock Chart & Stock Price History $2.23 -0.03 (-1.33%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$2.22 0.00 (-0.22%) As of 07/25/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ProQR Therapeutics Stock Price Performance The ProQR Therapeutics (PRQR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 18.62%, with a year-to-date return of -15.85%. In the past month, the stock has increased 3.24%, reflecting recent market activity. As of the latest close, ProQR Therapeutics traded at $2.23 with a market cap of $234.62 million and volume of 146,015 shares. Five years ago, the stock traded at $5.05, representing a 55.84% decrease over that period. At the time, it had a market cap of $251.24 million and a volume of 117,013 shares. Receive PRQR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.70%1 Month Performance+3.24%3 Month Performance+55.94%Year-To-Date Performance-15.85%1 Year Performance+18.62%5 Year Performance-55.84% PRQR Stock Chart for Saturday, July, 26, 2025 PRQR Chart by TradingView ProQR Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$2.26$2.23-1.33%$2.27$2.17146,015 shs$234.62 million07/24/2025$2.17$2.26+4.15%$2.39$2.11446,746 shs$237.78 million07/23/2025$2.28$2.17-4.82%$2.32$2.13264,074 shs$228.31 million07/22/2025$2.34$2.28-2.56%$2.34$2.2781,703 shs$239.88 million07/21/2025$2.26$2.34+3.54%$2.35$2.23240,199 shs$246.19 million07/18/2025$2.40$2.26-5.83%$2.47$2.25280,471 shs$237.78 million07/17/2025$2.35$2.40+2.13%$2.46$2.33161,703 shs$252.50 million07/16/2025$2.36$2.35-0.42%$2.37$2.27141,335 shs$247.25 million07/15/2025$2.48$2.36-4.84%$2.48$2.33231,908 shs$248.30 million07/14/2025$2.32$2.48+6.90%$2.51$2.33225,638 shs$260.92 million Get the Latest News and Ratings for PRQR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$2.36$2.32-1.69%$2.42$2.27186,473 shs$244.09 million07/10/2025$2.30$2.36+2.61%$2.38$2.22190,818 shs$248.30 million07/09/2025$2.20$2.30+4.55%$2.30$2.18322,027 shs$241.98 million07/08/2025$2.14$2.20+2.80%$2.22$2.12206,278 shs$231.46 million07/07/2025$2.14$2.14-0.14%$2.17$2.10190,621 shs$225.15 million07/04/2025$2.14$2.14$2.18$2.11175,653 shs$225.47 million07/03/2025$2.13$2.14+0.61%$2.18$2.11175,653 shs$225.47 million07/02/2025$2.01$2.13+5.97%$2.13$2.01342,247 shs$211.48 million07/01/2025$2.04$2.01-1.47%$2.09$2.00380,002 shs$211.47 million06/30/2025$2.04$2.04$2.13$2.00408,492 shs$214.63 million06/27/2025$2.16$2.04-5.56%$2.54$2.03998,760 shs$214.63 million06/26/2025$2.16$2.16$2.19$2.05536,165 shs$227.25 million06/25/2025$2.03$2.16+6.40%$2.20$2.00901,182 shs$227.25 million Related Companies Akebia Therapeutics Stock Chart Amphastar Pharmaceuticals Stock Chart Arcus Biosciences Stock Chart Dyne Therapeutics Stock Chart Spyre Therapeutics Stock Chart Verve Therapeutics Stock Chart Anavex Life Sciences Stock Chart Mineralys Therapeutics Stock Chart Avadel Pharmaceuticals Stock Chart Nurix Therapeutics Stock Chart Receive PRQR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRQR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProQR Therapeutics N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProQR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.